Furthermore, research has demonstrated that GA at concentrations up to 125 μg/mL can inhibit angiogenesis in glioma and cervical cancer cells by downregulating the signaling pathways of ADAM metallopeptidase domain 17 (ADAM17), Akt, ERK, and EGFR [196,201]. This evidence concerns the gene ADAM17 and cervical cancer.